These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22390809)

  • 1. Guidelines for the prevention of cardiovascular disease in women: international challenges and opportunities.
    Gupta D; Wenger NK
    Expert Rev Cardiovasc Ther; 2012 Mar; 10(3):379-85. PubMed ID: 22390809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing cardiovascular disease in women.
    Hayes SN
    Am Fam Physician; 2006 Oct; 74(8):1331-40. PubMed ID: 17087427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).
    McPherson R; Angus C; Murray P; Genest J;
    Am Heart J; 2001 Jun; 141(6):949-56. PubMed ID: 11376309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
    Mosca L; Linfante AH; Benjamin EJ; Berra K; Hayes SN; Walsh BW; Fabunmi RP; Kwan J; Mills T; Simpson SL
    Circulation; 2005 Feb; 111(4):499-510. PubMed ID: 15687140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global preventive policies. Strategies at European and worldwide level.
    Kotseva K
    Rev Esp Cardiol; 2008 Sep; 61(9):960-70. PubMed ID: 18775238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease prevention in women: a rapidly evolving scenario.
    Stranges S; Guallar E
    Nutr Metab Cardiovasc Dis; 2012 Dec; 22(12):1013-8. PubMed ID: 23123148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications.
    Gersh BJ; Sliwa K; Mayosi BM; Yusuf S
    Eur Heart J; 2010 Mar; 31(6):642-8. PubMed ID: 20176800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges for the management of hypertension in low-resource settings.
    Mendis S
    Ethn Dis; 2003; 13(2 Suppl 2):S67-70. PubMed ID: 13677416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond reproduction: women's health in today's developing world.
    Raymond SU; Greenberg HM; Leeder SR
    Int J Epidemiol; 2005 Oct; 34(5):1144-8. PubMed ID: 15951356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease prevention tailored for women.
    Engberding N; Wenger NK
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1123-34. PubMed ID: 18793115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The global burden of cardiovascular disease.
    Deaton C; Froelicher ES; Wu LH; Ho C; Shishani K; Jaarsma T
    J Cardiovasc Nurs; 2011; 26(4 Suppl):S5-14. PubMed ID: 21659814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional CVD risk factors and socio-economic deprivation in Roma minority population of Croatia.
    Zeljko H; Skarić-Jurić T; Narancic NS; Salihović MP; Klarić IM; Barbalić M; Starcević B; Lauc LB; Janićijević B
    Coll Antropol; 2008 Sep; 32(3):667-76. PubMed ID: 18982735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More similarities than differences: an international comparison of CVD mortality and risk factors in women.
    Gholizadeh L; Davidson P
    Health Care Women Int; 2008 Jan; 29(1):3-22. PubMed ID: 18176877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are at-risk New Zealand women receiving recommended cardiovascular preventive therapy?
    Bupha-Intr O; Rose SB; Lawton BA; Elley CR; Dowell AC
    N Z Med J; 2010 Feb; 123(1309):26-36. PubMed ID: 20186240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge and risk of cardiovascular disease in rural Alabama women.
    Hamner J; Wilder B
    J Am Acad Nurse Pract; 2008 Jun; 20(6):333-8. PubMed ID: 18588661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Representation of women in randomized clinical trials of cardiovascular disease prevention.
    Melloni C; Berger JS; Wang TY; Gunes F; Stebbins A; Pieper KS; Dolor RJ; Douglas PS; Mark DB; Newby LK
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):135-42. PubMed ID: 20160159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State of the heart: building science to improve women's cardiovascular health.
    Rosenfeld AG
    Am J Crit Care; 2006 Nov; 15(6):556-66; quiz 567. PubMed ID: 17053263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
    Albert MA; Glynn RJ; Buring J; Ridker PM
    Circulation; 2006 Dec; 114(24):2619-26. PubMed ID: 17116764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.